Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-04-26

Clinical Trial Update: Corticosteroids With Vedolizumab in Crohn's Disease [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for corticosteroids with vedolizumab in Crohn's disease was terminated; results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Corticosteroids (corticosteroids)
  • Vedolizumab (vedolizumab)

Snippet

Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: Crohn's Disease | Phase 4 | Status: TERMINATED | Results posted: 2019-04-26